Delivery Order SPE2DB22D2005-SPE2DB25FJTQ8
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 23, 2025, for the supply of Isotretinoin 30 mg capsules (30-count units) with a ceiling value of $7,051.35. This competitively awarded, firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 through December 2026. The place of performance is AmerisourceBergen's corporate...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 24, 2025, for the supply of Isotretinoin 30 mg capsules in quantities of 30, with a ceiling value of $2,347.10. This is a firm fixed price delivery order with no set-aside designation, indicating competitive award. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of September 25, 2025. This delivery...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 8, 2025, for the supply of Isotretinoin 30 mg capsules in quantities of ten. This competitively awarded, non-set-aside contract carries a ceiling value of $1,873.80 and features firm fixed-price pricing, with an ultimate completion date of September 9, 2025. The place of performance is listed as AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $3,982.61 on July 30, 2025, for the supply of Isotretinoin 30 mg capsules (30-count units). This is a firm fixed-price, competitively awarded contract with no set-aside designation and an ultimate completion date of July 31, 2025. The pharmaceutical product will be delivered to the place of performance in Conshohocken, Pennsylvania, where AmerisourceBergen Drug Corp maintains its corporate headquarters....
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Isotretinoin 30 mg capsules (30-count units) valued at $1,153.95, with a firm fixed price structure and ultimate completion date of September 23, 2025. This competitively awarded, non-set-aside contract represents a continuation order under AmerisourceBergen's existing pharmaceutical supply agreements with DLA. The work will be performed at the company's corporate office location in Conshohocken,...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on September 12, 2025, for the supply of Isotretinoin 30 mg capsules (30-count) with a contract ceiling value of $1,645.60. This firm fixed-price delivery order, with an ultimate completion date of September 15, 2025, was competitively awarded with no set-aside designation. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on June 16, 2025, for the supply of Isotretinoin 30 mg capsules in quantities of 10, with a contract ceiling value of $1,688.16. This competitively awarded, non-set-aside delivery order carries a firm fixed price structure and is scheduled for ultimate completion by June 17, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at...
- The Defense Logistics Agency awarded a competitive delivery order to AmerisourceBergen Drug Corp on September 2, 2025, for the supply of Isotretinoin 30 mg capsules (30-count) with a ceiling value of $1,978.20. This delivery order utilizes firm fixed-price pricing and represents a non-set-aside competitive award. The place of performance is located in Conshohocken, Pennsylvania, with an ultimate completion date of September 3, 2025. This award is issued as a child contract under...
- The Department of Defense's Medical Supply Chain awarded a delivery order contract to AmerisourceBergen Drug Corp on August 5, 2025, for the supply of Isotretinoin 30 mg capsules in quantities of 30 units, with a contract ceiling value of $17,955.69. This is a firm fixed-price delivery order with an ultimate completion date of August 6, 2025, and was awarded without a set-aside designation, indicating it was awarded through open competition. The contract is executed from AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Isotretinoin 30 mg capsules (30-count units) on September 15, 2025, with a ceiling value of $6,658.02 and a firm fixed price structure. This non-set-aside, competitively awarded contract is scheduled for completion by September 16, 2025, with performance occurring at the vendor's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a continuation of AmerisourceBergen's...
- SPE2DB22D2005Indefinite Delivery Contract
- SPE2DB22D2005-SPE2DB25FJTQ8Delivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Isotretinoin 30 mg capsules (30-count) on September 25, 2025, with a ceiling value of $13,584.48 under a firm fixed-price contract structure. This non-competitive set-aside award is classified as a child contract, indicating it stems from a larger vehicle—specifically AmerisourceBergen's $999.999 billion Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), which extends through December 2026. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order supports DLA's Medical Supply Chain operations, providing a critical pharmaceutical product to military and veteran healthcare systems. AmerisourceBergen Drug Corp serves as a major pharmaceutical distributor and primary vendor for federal medical procurement, with an extensive portfolio of brand-name and generic medications, vaccines, and specialized medical supplies. The award reflects the company's capability to fulfill federal medical supply requirements through its comprehensive IDC vehicle, which enables flexible procurement of pharmaceutical commodities across multiple therapeutic domains to support Defense Health Agency operations and other government healthcare systems worldwide. The contract is scheduled for ultimate completion by September 26, 2025.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $13.6k | 9/25/25 |